CosIng Checker
CosIng Checker
EU cosmetic ingredients, restrictions and safety
Login
13-market evidence comparison

Compare one cosmetic substance across markets

Enter one INCI name, chemical name, CAS or EC number. The tool combines EU annex evidence, linked ingredient identities and standalone official country records into one comparison.

A missing local record is shown as an evidence gap, never as a permission or safety conclusion.

Search the exact identity

For the strongest identity match, prefer CAS or EC when the official source supplies it.
Comparison query

CERAMIDE NG DILAURATE

Matching regulatory evidence was found in 0 of 13 market datasets.

Markets with evidence
0
Evidence gaps
13
Country records
0
EU annex records
0
No matching regulatory record was resolved. Try the exact CAS, EC or official INCI name. This result is an evidence gap across the indexed datasets, not proof that the substance is permitted or safe.

Resolved identity evidence

CAS:1219613-01-0
1 matched or reported name
CERAMIDE NG DILAURATE

Regulatory evidence by market

Status is the strongest matching record in the local dataset. Open the records to review exact conditions and legal scope.

MarketResultRecordsDataset coverageNext action
European Union
EU
No local match0
Complete annex dataset
Regulation (EC) 1223/2009 consolidated to 1 May 2026
No annex match only means that these five annexes did not return a match; CosIng identity data and other EU obligations still need review.
Great Britain
GB
No local match0
Complete consolidated annex dataset
GB retained Regulation 1223/2009 schedules, effective 15 August 2026
No annex match is not approval and does not cover Northern Ireland, which follows the applicable EU framework.
Canada
CA
No local match0
Complete Hotlist snapshot
Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
The Hotlist is an administrative compliance tool, not an exhaustive safety approval list.
New Zealand
NZ
No local match0
Complete schedules dataset
Cosmetic Products Group Standard schedules effective 1 January 2026
The searchable spreadsheet is an aid; the legal Group Standard and incorporated notices remain authoritative.
ASEAN
ASEAN
No local match0
Complete regional annex dataset
ASEAN Cosmetic Directive annexes 2026-1, 22 June 2026
Regional annex coverage does not replace member-state implementation dates, notifications or national deviations.
China
CN
No local match0
Complete prohibited catalogues plus official-source workflow
NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025
IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately.
Japan
JP
No local match0
Complete Standards appendices dataset
MHLW Standards for Cosmetics official English source and Japanese amendments checked for the imported snapshot
The Japanese text and subsequent notices are canonical; no local match is not a product-compliance conclusion.
South Korea
KR
No local match0
Complete current appendix dataset
MFDS Notice 2026-19, effective 18 March 2026
Korean source wording is canonical and other positive lists/notices may still apply to the formulation.
United States
US
No local match0
Complete enumerated federal ingredient rules
eCFR Title 21 issue date 27 August 2026
FDA has no general approved-cosmetic-ingredient catalogue; absence from these sections is not approval or proof of safety.
Australia
AU
No local match0
Complete cosmetic-relevant Poisons Standard subset plus official workflow
Therapeutic Goods (Poisons Standard—June 2026) Instrument 2026
An AICIS Inventory match is not cosmetic approval; no Inventory match can indicate a new, exempted, reported or confidential introduction.
Brazil
BR
No local match0
Complete prohibited dataset plus current restricted-list workflow
ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026
RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.
India
IN
No local match0
Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
Cosmetics Rules 2020 plus current BIS IS 4707 parts (1:2020, 2:2025, 3:2025, 4:2022)
The standards are separate controlled publications; absence from a locally indexed excerpt is not permission.
Saudi Arabia
SA
No local match0
Complete official list index
SFDA live prohibited/restricted lists, snapshot 30 August 2026
No list match is not permission; Gulf/SFDA product, claim, notification and technical requirements still apply.
No market rows match this filter.

Complete the official verification workflow

Ingredient evidence is only one layer. These market-specific steps identify the remaining checks before a compliance decision.

European Union · Complete annex dataset
  1. Confirm the exact INCI/CAS/EC identity.
  2. Review every matching Annex II–VI row and its conditions.
  3. Check SCCS opinions, CMR/nanomaterial rules and later amendments.
  4. Verify product classification, claims, labelling and responsible-person duties.
Open market coverage
Great Britain · Complete consolidated annex dataset
  1. Confirm INCI/CAS/EC identity.
  2. Review every current GB Annex II–VI match.
  3. Check commencement dates and later statutory instruments.
  4. Verify SCPN, responsible-person, safety-report and labelling duties.
Open market coverage
Canada · Complete Hotlist snapshot
  1. Search English/French names and CAS identifiers.
  2. Apply every restriction, concentration and label warning.
  3. Check Food and Drugs Act/Cosmetic Regulations requirements.
  4. Recheck the current Hotlist before notification or sale.
Open market coverage
New Zealand · Complete schedules dataset
  1. Search exact identity across Schedules 4–8.
  2. Apply use, concentration and warning conditions.
  3. Check hazardous-substance classification and Group Standard scope.
  4. Confirm the latest legal instrument, not only the spreadsheet.
Open market coverage
ASEAN · Complete regional annex dataset
  1. Search all ACD annexes by name and identifiers.
  2. Apply product type, maximum level and warning conditions.
  3. Confirm the target member state's adoption and transition date.
  4. Complete the local notification and responsible-company requirements.
Open market coverage
China · Complete prohibited catalogues plus official-source workflow
  1. Search the current NMPA IECIC List I and List II by Chinese name and identity.
  2. Check prohibited/restricted and positive lists in the current Safety and Technical Standards.
  3. Review technical purpose, use history and any monitoring period.
  4. Confirm Chinese labelling, safety assessment and filing/registration duties.
Open market coverage
Japan · Complete Standards appendices dataset
  1. Search Japanese/English identity and CAS where present.
  2. Apply category and maximum-amount conditions.
  3. Check later MHLW notices against the Japanese source.
  4. Verify marketing licence, notification, labelling and quasi-drug classification.
Open market coverage
South Korea · Complete current appendix dataset
  1. Match the Korean canonical substance name and identifiers.
  2. Review all Appendix 1 and 2 matches and conditions.
  3. Check functional-cosmetic and positive-list requirements where applicable.
  4. Confirm current MFDS notice, responsible seller and label obligations.
Open market coverage
United States · Complete enumerated federal ingredient rules
  1. Search Part 700 and all relevant colour-additive parts.
  2. Confirm colour additive identity, permitted uses, limits and certification status.
  3. Assess safety and adulteration under the FD&C Act.
  4. Complete MoCRA facility/product, adverse-event and label obligations where applicable.
Open market coverage
Australia · Complete cosmetic-relevant Poisons Standard subset plus official workflow
  1. Decide whether the product is a cosmetic or therapeutic good.
  2. Check the current Poisons Standard for every ingredient.
  3. Search AICIS Inventory terms and assessment certificates by exact identity.
  4. Determine introduction category, registration, reporting, records and labelling duties.
Open market coverage
Brazil · Complete prohibited dataset plus current restricted-list workflow
  1. Resolve Portuguese, INCI and CAS identity with the ANVISA crosswalk.
  2. Check the consolidated prohibited list including RDC 1.030/2026 changes.
  3. Apply RDC 1.029/2026 restrictions and the still-effective complementary rules.
  4. Verify Mercosur incorporation, regularisation, labelling and transition periods.
Open market coverage
India · Complete current Part 2 dataset plus official workflow for Parts 1, 3 and 4
  1. Confirm product class and current Cosmetics Rules/gazette amendments.
  2. Check all applicable parts of IS 4707 by exact identity.
  3. Apply Schedule S/other finished-product standards where relevant.
  4. Verify licence/import registration, labelling and testing requirements.
Open market coverage
Saudi Arabia · Complete official list index
  1. Search names and CAS across both SFDA lists.
  2. Open the cited restricted-entry detail and apply every condition.
  3. Check current SFDA/GSO technical regulations and updates.
  4. Complete eCosma notification, label and responsible-party requirements.
Open market coverage

What this comparison can and cannot decide

1. Resolve identity

CAS and EC tokens are extracted exactly. Name searches use normalized official names and linked identities.

2. Compare evidence

The strongest matching status and direct records are shown separately for every supported market.

3. Finish verification

Product type, concentration, purity, warnings, claims, classification and later amendments still require official review.